| Species | Reactivity Confirmed | Notes | Source(s) |
|---|---|---|---|
| Human | Predicted/Confirmed | Primary target species | |
| Mouse | Confirmed | Proteintech validation (WB/IF) | |
| Rat | Confirmed | Proteintech validation (WB/IF) |
PLA2G4E (Group IVE phospholipase A2) is a calcium-dependent enzyme involved in lipid metabolism, particularly in synthesizing N-acyl ethanolamines (NAEs) like anandamide. Its activity impacts inflammation, cell signaling, and lysosomal membrane integrity .
Lysosomal Membrane Permeabilization (LMP):
PLA2G4E inhibition via Mir504-5p or shRNA reduces LMP-induced necroptosis, enhancing survival of ischemic skin flaps in murine models .
Enzymatic Mechanism:
Transfers acyl chains from phosphatidylcholine to phosphatidylethanolamine, generating precursors for bioactive lipids .
| Application | Dilution Range | Observed MW | Validated Cell Lines | Source(s) |
|---|---|---|---|---|
| Western Blot | 1:1,000–1:8,000 | 98 kDa | A431, K-562, NIH/3T3 | |
| Immunofluorescence | 1:200–1:800 | N/A | A431 | |
| IHC | 1:50–1:100 | N/A | Human tissues |
Ischemic Tissue Survival:
PLA2G4E knockdown via AAV-shRNA improved random-pattern skin flap survival by 37% in mice by mitigating LMP and necroptosis .
Neurological Studies:
Linked to NAE biosynthesis in the brain, affecting endocannabinoid signaling pathways .
High Specificity: Detects endogenous PLA2G4E without cross-reactivity to related phospholipases .
Broad Compatibility: Validated in FFPE tissues, frozen sections, and cell cultures .
Dilution: Optimize for each assay (e.g., 1:50–1:100 for IHC, 1:40,000 for ELISA) .
Controls: Use A431 (positive) and Pla2g4e knockdown models (negative) .